General form for registration of securities under the Securities Act of 1933

Equity Incentive Plans and Stock-Based Compensation

v3.25.2
Equity Incentive Plans and Stock-Based Compensation
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Equity Incentive Plans and Stock-Based Compensation

Note 11. Equity Incentive Plans and Stock-Based Compensation

 

As of June 30, 2025, the Company had a remaining allocated reserve of 0 shares of its common stock for issuance under its 2021 EIP, which provides for the granting of stock options, RSUs and stock appreciation rights to employees, directors, and consultants of the Company. As of June 30, 2025, the Company had an allocated reserve of 148,897 shares of its common stock for issuance under its 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of June 30, 2025, the Company had not begun any offering periods for the 2021 ESPP.

 

Stock options

 

Activity under the 2021 EIP is set forth below:

 

    Options     Weighted-
Average
Exercise Price
    Weighted-
Average
Remaining
Contractual
Term in years
 
      (In thousands)       (Per share data)       (Years)  
Outstanding as of December 31, 2023     25     $ 320.25       6.2  
Granted         $          
Exercised     (3 )   $ 94.50          
Forfeited or expired     (1 )   $ 426.45          
Outstanding as of June 30, 2024     21     $ 352.95       5.9  
Options vested and expected to vest as of June 30, 2024     21     $ 352.95          
Vested and exercisable as of June 30, 2024     21     $ 356.40          
                         
Outstanding as of December 31, 2024     18     $ 380.70       5.0  
Granted         $          
Exercised         $          
Forfeited or expired     (14 )   $ 166.70          
Outstanding as of June 30, 2025     4     $ 1,022.11       4.8  
Options vested and expected to vest as of June 30, 2025     4     $ 1,022.11          
Vested and exercisable as of June 30, 2025     4     $ 1,022.11          

 

As of June 30, 2025 and December 31, 2024, there is no aggregate intrinsic value of options outstanding.

 

As of June 30, 2025, total unrecognized compensation cost related to options was immaterial and is expected to be recognized over a weighted-average period of less than a year.

 

For the six months ended June 30, 2025, there were no options granted.

 

Restricted Stock Units

 

The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.

 

 

The following table summarizes outstanding and expected to vest RSUs as of June 30, 2025 and 2024 and their activity during the six months ended June 30, 2025 and 2024:

 

    Number
of Shares
    Weighted-
Average
Grant Date
Fair Value
    Aggregate
Intrinsic
Value
 
      (In thousands)       (Per share data)       (In thousands)  
Balance as of December 31, 2023     38     $ 1,020.00     $ 7,940  
Granted     9       124.50        
Released     (5 )     1,223.10        
Cancelled     (5 )     1,003.20        
Balance as of June 30, 2024     37     $ 766.95     $ 1,812  
Expected to vest as of June 30, 2024     37     $ 766.95     $ 1,812  
                         
Balance as of December 31, 2024     13     $ 714.30     $ 132  
Granted     1,070       11.05        
Released     (104 )     28.07        
Cancelled     (90 )     30.91        
Balance as of June 30, 2025     889     $ 16.51     $ 6,400  
Expected to vest as of June 30, 2025     889     $ 16.51     $ 6,400  

 

The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of June 30, 2025, there was $13.9 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 3.1 years. As of June 30, 2024, there was $24.6 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.7 years.

 

Earnout Shares–Employees

 

The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.

 

Stock-based Compensation Expense

 

The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:

 

    2025     2024     2025     2024  
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2025     2024     2025     2024  
    (In thousands)     (In thousands)  
Restricted stock units   $ 1,834     $ 3,101     $ 5,425     $ 6,930  
Stock options     1       39       5       99  
Earnout shares–employees     574       1,107       1,053       2,305  
Stock based compensation expense   $ 2,409     $ 4,247     $ 6,483     $ 9,334  

 

 

The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in cost of revenue and operating expenses on the statements of operations:

 

    2025     2024     2025     2024  
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2025     2024     2025     2024  
    (In thousands)     (In thousands)  
Cost of 3D Printer   $ 474     $ 269     $ 613     $ 658  
Cost of Support services     125       138       194       333  
Research and development     613       1,130       1,256       2,680  
Selling and marketing     368       862       607       1,916  
General and administrative     829       1,848       3,813       3,747  
Stock based compensation expense   $ 2,409     $ 4,247     $ 6,483     $ 9,334  

 

Note 11. Equity Incentive Plans & Stock-Based Compensation

 

In 2014, the Company adopted its 2014 equity incentive plan (the “2014 Plan”) which provides for the granting of stock options, restricted stock awards and stock appreciation rights to employees, directors, and consultants of the Company.

 

Awards granted under the 2014 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of stock options grants shall not be less than 110% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors. Awards generally vest based on continuous service over four years. Awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2021 Plan (as defined below).

 

In 2021, the Company adopted its 2021 Equity Incentive Plan (the “2021 EIP”) which provides for the granting of stock options, restricted stock units (“RSUs”) and stock appreciation rights to employees, directors, and consultants of the Company. The Company initially reserved 81,460 shares of its common stock for issuance under the 2021 EIP. In April 2024, pursuant to the evergreen provisions of the 2021 EIP, the Company registered an additional 24,612 shares of common stock for issuance under the 2021 EIP.

 

As of December 31, 2024, the Company has an allocated reserve of 46,456 shares of its common stock for issuance under the 2021 EIP.

 

In addition, the Company adopted its 2021 Employee Stock Purchase Plan (“2021 ESPP”). The Company initially reserved 6,978 shares of its common stock for issuance under the 2021 ESPP. In March 2022, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 3,491 shares of common stock for issuance under the 2021 ESPP.

 

In March 2023, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 3,573 shares of common stock for issuance under the 2021 ESPP. In April 2024, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 4,917 shares of common stock for issuance under the 2021 ESPP.

 

As of December 31, 2024, the Company has an allocated reserve of 18,958 shares of its common stock for issuance under the 2021 ESPP. As of December 31, 2024, the Company had not begun any offering periods for the 2021 ESPP.

 

Awards granted under the 2021 EIP generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of stock options grants shall not be less than 110% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors. Awards generally vest based on continuous service over 4 years. Awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2021 Plan.

 

 

Velo3D, Inc.

Notes to Consolidated Financial Statements

 

Stock options

 

Activity under the Company’s stock option plans is set forth below:

 

    Options     Weighted-Average
Exercise Price
    Weighted-Average
Remaining
Contractual Term
 
    (In thousands)     (Per Share Data)     (Years)  
Outstanding as of December 31, 2022     33     $ 283.50       7.3  
Granted         $          
Exercised     (4 )   $ 136.50          
Forfeited or expired     (4 )   $ 152.25          
Outstanding as of December 31, 2023     25     $ 320.25       6.2  
Options vested and expected to vest as of December 31, 2023     25     $ 320.25          
Vested and exercisable as of December 31, 2023     24     $ 325.50          
                         
Outstanding as of December 31, 2023     25     $ 320.25       6.2  
Granted         $          
Exercised     (3 )   $ 94.50          
Forfeited or expired     (4 )   $ 242.25          
Outstanding as of December 31, 2024     18     $ 380.70       5.0  
Options vested and expected to vest as of December 31, 2024     18     $ 380.70          
Vested and exercisable as of December 31, 2024     18     $ 380.10          

 

As of December 31, 2024, there is no aggregate intrinsic value of options outstanding. As of December 31, 2023, there was $2.3 million of aggregate intrinsic value of options outstanding . Intrinsic value of options exercised for the years ended December 31, 2024 and 2023 was $0.2 million and $4.6 million, respectively. The total grant date fair value of options vested was $0.1 million and $0.7 million for the years ended December 31, 2024 and 2023, respectively.

 

As of December 31, 2024, there is no unrecognized compensation cost related to options.

 

Restricted Stock Units

 

The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.

 

 

Velo3D, Inc.

Notes to Consolidated Financial Statements

 

The following table summarizes outstanding and expected to vest RSUs as of December 31, 2024 and 2023 and their activity during the year ended December 31, 2024 and 2023:

  

    Number of Shares     Weighted-Average
Grant Date Fair Value
    Aggregate Intrinsic Value  
    (In thousands)     (Per Share Data)     (In thousands)  
Balance as of December 31, 2022     19     $ 2,352.00     $ 17,202  
Granted     41       807.90       33,070  
Released     (11 )     1,689.75       9,148  
Cancelled     (11 )     1,852.80       7,773  
Balance as of December 31, 2023     38     $ 1,020.00     $ 7,940  
Expected to vest as of December 31, 2023     38     $ 1,020.00     $ 7,940  
                         
Balance as of December 31, 2023     38     $ 1,020.00     $ 7,940  
Granted     32       49.35       1,549  
Released     (38 )     428.10       1,276  
Cancelled     (19 )     808.65       1,050  
Balance as of December 31, 2024     13     $ 714.30     $ 132  
Expected to vest as of December 31, 2024     13     $ 714.30     $ 132  

 

The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of December 31, 2024, there was $11.0 million of unrecognized compensation cost related to 0.01 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.3 years. As of December 31, 2023, there was $35.8 million of unrecognized compensation cost related to 1.3 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 3.0 years.

 

Earnout Shares - Employees

 

The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.

 

 

Velo3D, Inc.

Notes to Consolidated Financial Statements

 

Stock-based Compensation Expense

 

The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:

  

    2024     2023  
    December 31,  
    2024     2023  
    (In thousands)  
Restricted stock units   $ 9,637     $ 16,575  
Stock options     121       515  
Earnout shares - employees     3,958       5,783  
Stock based compensation expense    $ 13,716     $ 22,873  

 

The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in operating expenses on the statements of operations:

 

    2024     2023  
    December 31,  
    2024     2023  
    (In thousands)  
Research and development   $ 4,256     $ 11,415  
Selling and marketing     2,708       5,689  
General and administrative     6,752       5,769  
Stock based compensation expense    $ 13,716     $ 22,873  

 

The following sets forth the total stock-based compensation expense by type of award included in cost of revenue in the statements of operations:

   

    2024     2023  
    December 31,  
    2024     2023  
    (In thousands)  
Restricted stock units   $ 1,644     $ 1,995  
Stock options     4       63  
Stock based compensation expense     $ 1,648     $ 2,058  

 

The following sets forth the total stock-based compensation expense for the stock options, and RSUs included in cost of revenue on the statements of operations:

 

    December 31,  
    2024     2023  
    (In thousands)  
Cost of 3D Printer   $ 999     $ 1,622  
Cost of support services     649       436  
Stock based compensation expense      $ 1,648     $ 2,058  

 

 

Velo3D, Inc.

Notes to Consolidated Financial Statements